New study suggests Palmitoylethanolamide (PEA) could be breakthrough treatment for Alzheimers

A new study has found that N-Palmitoylethanolamide (PEA), a curious organic compound increasingly attracting the interest of medical researchers, greatly reduces symptoms of Alzheimers Disease (AD) in animals. The study, conducted by scientists from the University of Ferrara in Italy and published in Frontiers, looked at pre-clinical data from both in vitro and in vivo 

Continue Reading…